|1||NCT00023426||Completed||TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis||
||150||All||18 Years and older (Adult, Older Adult)||NCT00023426||CDC-NCHSTP-2404
|July 1999||February 2003||September 10, 2001||September 13, 2005||
|2||NCT02581930||Active, not recruiting||Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma||
||18||All||18 Years and older (Adult, Older Adult)||NCT02581930||NCI-2015-01744
|August 17, 2016||February 10, 2018||October 21, 2015||December 24, 2018||
† Study has passed its completion date and status has not been verified in more than two years.